We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Sanofi-Aventis Puts a New GC Workhorse Through its Paces: A Case Study

Read time: Less than a minute

Thermo Fisher Scientific has announced a customer case study on the effective adoption of upgraded gas chromatography (GC) technology into an existing workflow with improved results and minimal effort.

Dr. Dietrich Hilke, Head of Laboratory, Sanofi-Aventis, Deutschland GmbH, Frankfurt, and his team participated in the planning, testing, and evaluation of a new GC platform.

Dr. Hilke’s laboratory analyzes 500 to 700 sample batches per year in a regulated environment for quality control of excipients, drug substances, and drug products.

The team was able to directly transfer existing methods to the new GC system thus saving large amounts of time and effort.

The new system has yielded better results than existing instruments, and Dr. Hike says, “The user-exchange of the instant connect injector and detector modules is quick and functional. The low temperature of the injection head has the practical advantage of replacing a new liner without losing any time. The simple and quick adaptation from liquid to headspace sampling is a great advance and is very helpful for daily user operations. Overall, the Thermo Scientific™ TRACE™ 1310 GC is very flexible and user-friendly for a wide range of applications.”